These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25936727)

  • 1. Surveillance of adverse events following immunization in China: Past, present, and future.
    Liu D; Wu W; Li K; Xu D; Ye J; Li L; Wang H
    Vaccine; 2015 Jul; 33(32):4041-6. PubMed ID: 25936727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active surveillance for adverse events following immunization.
    Crawford NW; Clothier H; Hodgson K; Selvaraj G; Easton ML; Buttery JP
    Expert Rev Vaccines; 2014 Feb; 13(2):265-76. PubMed ID: 24350637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deaths reported to national surveillance for adverse events following immunization in China, 2010-2015.
    Wu W; Liu D; Nuorti JP; Li K; Xu D; Ye J; Zheng J; Cao L; Wang H
    Vaccine; 2019 Feb; 37(9):1182-1187. PubMed ID: 30709723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A global survey of adverse event following immunization surveillance systems for pregnant women and their infants.
    Cassidy C; MacDonald NE; Steenbeek A; Ortiz JR; Zuber PL; Top KA
    Hum Vaccin Immunother; 2016 Aug; 12(8):2010-2016. PubMed ID: 27159639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine Safety and Surveillance for Adverse Events Following Immunization (AEFI) in India.
    Joshi J; Das MK; Polpakara D; Aneja S; Agarwal M; Arora NK
    Indian J Pediatr; 2018 Feb; 85(2):139-148. PubMed ID: 29170922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of death cases in Shenyang City, China, for immunization adverse event surveillance, 2009-2021.
    Gao D; Dong G; Zhu L; Jia N; Sun B
    Hum Vaccin Immunother; 2023 Aug; 19(2):2263225. PubMed ID: 37782096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse events following immunization: is this time for the use of WHO causality assessment?
    Tafuri S; Gallone MS; Calabrese G; Germinario C
    Expert Rev Vaccines; 2015 May; 14(5):625-7. PubMed ID: 25805053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine surveillance of adverse events following immunization as an important tool to monitor vaccine safety.
    Alicino C; Merlano C; Zappettini S; Schiaffino S; Della Luna G; Accardo C; Gasparini R; Durando P; Icardi G
    Hum Vaccin Immunother; 2015; 11(1):91-4. PubMed ID: 25483520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review of reporting rates of adverse events following immunization: an international comparison of post-marketing surveillance programs with reference to China.
    Guo B; Page A; Wang H; Taylor R; McIntyre P
    Vaccine; 2013 Jan; 31(4):603-17. PubMed ID: 23200940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance for adverse events following immunization from 2008 to 2011 in Zhejiang Province, China.
    Hu Y; Li Q; Lin L; Chen E; Chen Y; Qi X
    Clin Vaccine Immunol; 2013 Feb; 20(2):211-7. PubMed ID: 23239804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surveillance of adverse events following immunization in Henan Province, China between 2010-2011].
    Ye Y; Wang CS; Ma YT; Lu MX; Zhang XX; Zhang YY; Guo WS
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):466-71. PubMed ID: 23791064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applicability of the Brighton Collaboration Case Definition for seizure after immunization in active and passive surveillance in Canada.
    Top KA; Constantinescu CM; Laflèche J; Bettinger JA; Scheifele DW; Vaudry W; Halperin SA; Law BJ
    Vaccine; 2013 Nov; 31(48):5700-5. PubMed ID: 24099871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surveillance of adverse events following immunization in Minhang district of Shanghai from 2007 to 2010].
    Zhang LP; Yu F; Jin BF; Wang Y; Xu HL; DU Y
    Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):859-64. PubMed ID: 23302620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis on the surveillance of adverse events following immunization in China, 2007-2008].
    Wu WD; Liu DW; Wu BB
    Zhongguo Yi Miao He Mian Yi; 2009 Dec; 15(6):481-90, 538. PubMed ID: 20518320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events following HPV vaccination, Alberta 2006-2014.
    Liu XC; Bell CA; Simmonds KA; Svenson LW; Russell ML
    Vaccine; 2016 Apr; 34(15):1800-5. PubMed ID: 26921782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-marketing safety surveillance for inactivated and live-attenuated Japanese encephalitis vaccines in China, 2008-2013.
    Wu W; Liu D; Li K; Nuorti JP; Nohynek HM; Xu D; Ye J; Zheng J; Wang H
    Vaccine; 2017 Jun; 35(29):3666-3671. PubMed ID: 28552510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of adverse events following immunization during pregnancy and the newborn period.
    Fulton TR; Narayanan D; Bonhoeffer J; Ortiz JR; Lambach P; Omer SB
    Vaccine; 2015 Nov; 33(47):6453-65. PubMed ID: 26413879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cohort event monitoring to determine the adverse events following administration of mouse brain derived, inactivated Japanese Encephalitis vaccine in an endemic district in Sri Lanka.
    De Alwis KN; Abeysinghe MR; Wickramesinghe AR; Wijesinghe PR
    Vaccine; 2014 Feb; 32(8):924-30. PubMed ID: 24406391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of adverse events following immunization in Zhejiang, China, 2019: a retrospective cross-sectional study based on the passive surveillance system.
    Pan X; Lv H; Chen F; Wang Y; Liang H; Shen L; Chen Y; Hu Y
    Hum Vaccin Immunother; 2021 Oct; 17(10):3823-3830. PubMed ID: 34170800
    [No Abstract]   [Full Text] [Related]  

  • 20. Reporting of adverse events following immunization in Australia.
    Isaacs D; Lawrence G; Boyd I; Ronaldson K; McEwen J
    J Paediatr Child Health; 2005 Apr; 41(4):163-6. PubMed ID: 15813867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.